Kevin McCarthy

Kevin McCarthy has served as Director of the Company since our founding in 1991 and became our Treasurer, Secretary and CFO in 2018. Mr. McCarthy also served as Senior Vice President and Chief Financial Officer from August 1991 until 2001.

Prior to re-joining Pherin as an officer, Mr. McCarthy was Executive Vice President of Shasta Crystals, a materials science company developing crystalline materials for high power military grade lasers, industrial lasers and medical lasers. Mr. McCarthy holds a B.S. degree from San Francisco State University and an MBA degree from California State University, Chico.

Toby Rosenblatt

Toby Rosenblatt has served as a member of the Board of Directors since 1992, became Chairman of the Board of Directors in July 2018 and was made Executive Chairman in September of 2020. Mr. Rosenblatt is President of Founders Investments Ltd, a private investment firm. He has served as a director of several small businesses in the fields of financial services and biotechnology as well as a director of several BlackRock mutual funds.

Mr. Rosenblatt serves on the boards of several charitable foundations and nonprofits serving healthcare and education. Mr. Rosenblatt holds a BA degree from Yale University and an MBA degree from Stanford University.

Michael B. Liebowitz, MD

Michael B. Liebowitz, MD is Associate Professor of Clinical Psychiatry at Columbia University, NY; Director of the Anxiety Disorders Clinic at the New York State Psychiatric Institute and Managing Director of the Medical Research Network. Dr. Liebowitz is recognized as one of the world's leading researchers in the field of anxiety disorders. He assists us with the clinical development of our anxiety program.

Brad Katz, MD, PhD

Dr. Katz is recognized as a leading researcher in the field of migraines. He is a professor of ophthalmology and visual sciences at the John A Moran Eye Center, University of Utah Health Sciences Center, Salt Lake City, Utah, USA. He holds adjunct appointments in the University’s Departments of Neurology and Neurosurgery.

Dr. Katz's University of Utah Profile

In addition to the clinical and surgical care of patients, Dr. Katz is responsible for training medical students, residents, and fellows.

Carla B. Washington, PhD
Chair of Scientific Advisory Board

Dr. Washington is a formally trained clinical pharmacology/translational medicine leader/scientist with over 20 years drug development experience with small and large molecules. She has demonstrated success in the design, execution, analysis, and interpretation of clinical pharmacology and translational medicine studies for product candidates. 

She has served as Director of Clinical Pharmacology and Clinical Development for Pharmaceutical companies such as Roche, Genetech, Sugen, Theravance, Global Blood Therapeutics and others. Dr. Washington is a strategic leader/thinker with a broad knowledge of therapeutic areas including hematology (sickle cell disease), oncology, virology (HIV, HCV andCMV), pulmonary (idiopathic pulmonary fibrosis) and anti-infectives with experience in all phases of clinical development (Phase 1 – Phase IV).